Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Orot Luces is an impact investment firm providing hybrid venture capital and private equity funding to scale innovative healthcare companies and oncology breakthroughs across Europe and beyond. The firm focuses on investments that enhance patient outcomes through new medical technologies, particularly in cancer care innovation. They invest across various stages, including Pre-seed, Seed, Seed+ (Extension), Series A, and Series A+ (Extension), with a hands-on approach to support the growth and development of their portfolio companies.
Portfolio
No portfolio companies in this dataset yet.
Q&A
- What is Orot Luces's primary investment focus?
- Orot Luces is an impact investment fund primarily focused on the oncology sector, aiming to transform cancer care.
- What specific areas within oncology does Orot Luces target?
- Orot Luces focuses on diagnosis, therapeutics, and digital health within the oncology sector, identifying these as areas with high potential for positive impact on survivability and quality of life.
- When was Orot Luces founded?
- Orot Luces was founded in 2015.
- Who is a key member of the Orot Luces leadership team?
- Avner Goldenberg serves as the President of Orot Luces and is a founder of the firm.
- Who are the Managing Partners at Orot Luces?
- Ron Streichman and Roy Goldenberg are Managing Partners at Orot Luces.
- Where is Orot Luces headquartered?
- Orot Luces is headquartered in Tel Aviv-Yafo, Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Orot Luces Ltd. |
|---|---|
| Founded | 2015-10 |